IL6 and metabolic dysfunction-associated steatotic liver disease: Even though LPS-induced steatosis is characterized by hepatic insulin resistance and the higher expression of tumor necrosis factor-α, IL-1 and IL-6 [29, 30], similar to the high-fat diet model, there are also some features that distinguish it from common NAFLD models.